Foltyn, M., Thiepold, A., Harter, P. N., Baumgarten, P., Mittelbronn, M., Urban, H., . . . Ronellenfitsch, M. W. (2016). OS1.4 Current treatment regimens induce the mTORC1 inhibitor REDD1 in human glioblastoma cells: Implications for treatment efficacy. Neuro Oncol.

Foltyn, M., A. Thiepold, P. N. Harter, P. Baumgarten, M. Mittelbronn, H. Urban, J. P. Steinbach, e M. W. Ronellenfitsch. "OS1.4 Current Treatment Regimens Induce the MTORC1 Inhibitor REDD1 in Human Glioblastoma Cells: Implications for Treatment Efficacy." Neuro Oncol 2016.

Foltyn, M., et al. "OS1.4 Current Treatment Regimens Induce the MTORC1 Inhibitor REDD1 in Human Glioblastoma Cells: Implications for Treatment Efficacy." Neuro Oncol 2016.